Latest News about KYMR
Recent news which mentions KYMR
During the second quarter, Kymera Therapeutics (KYMR) reported an 8-cent decline in earnings per share
August 12, 2022
Tickers
KYMR
From Best Stocks
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
From InvestorPlace
Executives Buy Around $141M Of 4 Stocks
May 10, 2022
From Benzinga
81 Biggest Movers From Yesterday
May 05, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
May 04, 2022
From Benzinga
80 Biggest Movers From Yesterday
May 04, 2022
From Benzinga
Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher
May 03, 2022
From Benzinga
Why Kymera Therapeutics Shares Are Falling Today
May 03, 2022
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
May 03, 2022
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2022
From Benzinga
From Benzinga
From Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.